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The present study investigated the antiobesity effect of Achyranthes bidentata Blume root water extract in a 3T3-L1 adipocyte
differentiation model and rats fed with a high-fat diet. To investigate the effect of Achyranthes bidentata Blume on adipogenesis
in vitro, differentiating 3T3-L1 cells in adipocyte-induction media were treated every two days withAchyranthes bidentata Blume at
various concentrations (1 to 25𝜇g/mL) for eight days. We found that Achyranthes bidentata Blume root inhibited 3T3-L1 adipocyte
differentiation without affecting cell viability, and Western blot analysis revealed that phospho-Akt expression was markedly
decreased, whereas there was no significant change in perilipin expression. Furthermore, administration of Achyranthes bidentata
Blume root (0.5 g/kg body weight for six weeks) to rats fed with a high-fat diet significantly reduced body weight gain without
affecting food intake, and the level of triglyceride was significantly decreased when compared to those in rats fed with only a high-
fat diet. These results suggest that Achyranthes bidentata Blume root water extract could have a beneficial effect on inhibition of
adipogenesis and controlling body weight in rats fed with a high-fat diet.
1. Introduction
Obesity is caused by the accumulation of excessive fat in
adipocytes as triglyceride as well as an increased number of
adipocytes. Furthermore, this metabolic disease poses high
risk for cardiovascular diseases, hypertension, respiratory
dysfunction, type 2 diabetes mellitus, certain types of can-
cer, osteoarthritis, dyslipidemia, ischemic heart disease, and
stroke [1, 2].
Differentiation of preadipocytes to mature adipocytes is
accompanied by changes in morphology and lipid accumu-
lation within the cells. Therefore, the antiadipogenic effect
of potential drug candidates could be represented by the
reduction of triglyceride formation in 3T3-L1 adipocyte
differentiation. Several signal transduction pathways have
been found to play an important role in adipocyte differ-
entiation and lipolysis. PKB/Akt is a downstream signal of
phosphatidylinositol-3-kinases (PI-3-Kinases) pathway that
is essential for adipogenesis. For example, inhibition of PI-
3 kinase by an inhibitor blocked insulin-induced 3T3-L1
adipocyte differentiation [3, 4]. On the other hand, protein
kinase A exerts its lipolysis effect through its downstream tar-
get, perilipin, which is highly expressed during adipogenesis.
Moreover, it is well known that overexpression of perilipin
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A decreases lipolysis by hormone-sensitive lipase (HSL) and
lipid turnover resulting in increases in storage of triglyceride
in adipocytes [5, 6].
Despite the fact that medication for the treatment of
obesity has short-term benefits for weight loss by suppression
of appetite, they are often associatedwith side effects and have
potential for drug abuse. Rebound weight gain is also con-
sidered a major side effect after the cessation of medication
use [7]. Recently,many herbalmedicines and their derivatives
have drawn attention because of their beneficial effect on the
treatment of obesity without causing significant side effects or
low risk for addiction [8]. For instance, a number of animal
studies showed that many herbal medicines such as ginseng
[9], Rhus verniciflua Stokes [10], Juniperus chinensis [11], and
Momordica charantia [12] are effective in reducing weight
gain in high fat-induced obesity animal models.
Achyranthes bidentata Blume (ABB), a member of Ama-
ranthaceae, has been traditionally used for fever, asthma,
rheumatism, headache, and hypertension [13]. Recently, it has
been reported that ABB extract prevents glutamate-induced
cell damage in cultured hippocampal neurons and induces
nerve growth and neural differentiation [14–16]. However,
till now, effects of ABB on adipogenesis and its molecular
mechanism have not been studied. The present study was
designed to investigate the potential antiadipogenic effects
of ABB water extract in 3T3-L1 adipocyte differentiation. In
addition to these cell studies, ABB was orally administered to
high-fat-diet-induced obese rats to demonstrate its beneficial
effect on obesity in vivo.
2. Materials and Methods
2.1. Materials. Ten herbs including Achyranthes bidentata
Blume (ABB), were purchased from the Oriental Medicine
Department of Kyung Hee Medical Center, Kyung Hee Uni-
versity (Seoul, Korea). Dulbecco’s modified Eagle’s medium
(DMEM) and antibiotics were obtained from Gibco/BRL
(Grand Island, NY, USA). Oil red O, 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), isobutyl-
methylxanthine (IBMX), dexamethasone, and insulin were
purchased from Sigma (St. Louis, MO, USA). All antibodies
were obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, USA) and Abcam (Cambridge, UK).
2.2. Preparation of Herbal Extracts. The dried herbs were
soaked in cold distilled water overnight and then extracted
by boiling for 3 hours at 100∘C. The aqueous extracts were
filtered through distilled gauze and concentrated by an eva-
porator. The extracted herbal medicines were dried with a
freeze dryer and stored at −20∘C until the experiment was
performed.
2.3. 3T3-L1 Cell Culture and Adipocyte Differentiation.
Murine 3T3-L1 preadipocytes (ATCC, Manassas, VA, USA)
were maintained in DMEM supplemented with 10% (v/v)
BCS and 1% (v/v) antibiotics in a humidified atmosphere
of 95% air and 5% CO
2
at 37∘C. The cells were seeded at a
density of 2.4 × 105 cells/cm2 and grown until cells reached
confluency. Differentiation to adipocytes was induced by
adipocyte-induction media I (DMEM containing 10% [v/v]
FBS, 1% [v/v] antibiotics, 0.5mM IBMX, 1 𝜇M dexametha-
sone, and 10 𝜇g/mL insulin). After three days, cells were
changed to adipocyte-inductionmedia II (DMEMcontaining
10% [v/v] FBS, 1% [v/v] antibiotics, and 10 𝜇g/mL insulin) for
5 additional days. All media were changed every 2 days.
2.4. Treatment ofHerb Extracts on 3T3-L1 Cells. Herb extracts
were dissolved in adipocyte-induction media and filtered
through 0.2𝜇m-pore syringe filters. Differentiating 3T3-L1
cells were treated every 2 days with a herb in adipocyte-
inductionmedia at various concentrations (1 to 25𝜇g/mL) for
8 days. The concentration used in the experiment was based
on the dry weight of the extract.
2.5. Oil Red O Staining. 3T3-L1 adipocytes that were treated
as described above were washed with phosphate-buffered
saline (PBS, pH 7.4) and fixed with 4% paraformaldehyde
(PFA). After incubation for 1 hour, cells were rinsed with
PBS and were stained with oil red O solution (0.2% [w/v] in
isopropanol) for 1.5 hours at room temperature. To obtain the
image of cell lipid droplets stained with oil red O, appearance
was recorded by microscopic at 200x magnification with
an Axiovert S 100 (Carl Zeiss) equipped with an AxioCam.
Subsequently, oil red O dye in lipid droplets was eluted into
isopropanol and the absorbance was measured at 490 nm
using an ELISA reader (Emax, USA) (𝑛 = 4).
2.6. Cell Viability Assay. Cell viability was determined by
MTT assay. On day 8, 100 𝜇L of MTT solution (5mg/mL)
was added to differentiated 3T3-L1 cells. After incubation
at 37∘C for 2 hours, the synthesized formazan crystals were
dissolved in dimethyl sulfoxide (DMSO). Finally, absorbance
wasmeasured at 570 nm using an ELISA reader (Emax, USA)
(𝑛 = 4). Data was calculated as a percentage ofMTT compare
to control cells.
2.7. Western Blot Analysis. On day 8 after the initiation of
differentiation treated with various concentrations of ABB
(0–25𝜇g/mL), cells were rinsed three times with cold PBS
and scraped into lysis buffer (20mM Tris-HCl [pH 7.4],
150mM NaCl, 10% glycerol, 2% Nonidet P-40, 1mM EDTA,
20mM sodium fluoride, 30mM sodium pyrophosphate,
0.2% sodium dodecyl sulfate (SDS), 0.5% sodium deoxy-
cholate, 1mM phenylmethylsulfonyl fluoride (PMSF), 1mM
dithiothreitol (DTT), and 1mM sodium vanadate). The cell
lysate was centrifuged for 20min at 12,000×g and the super-
natant was collected. Each protein extract (5, 10, or 20𝜇g)
was loaded on 10% SDS-polyacrylamide gel and the separated
proteins were blotted onto 0.2𝜇m polyvinylidene difluoride
(PVDF) membranes (Bio-Rad, Hercules, CA, USA) using a
semidry transfer apparatus (Trans-Blot SD; Bio-Rad). The
membranes were then incubated with primary antibody
(Akt-p [1 : 1000], Akt [1 : 2000], perilipin [1 : 2000], and actin
[1 : 1000]) diluted in blocking solution at 4∘Covernight.Mem-
branes were probed with horseradish peroxidase-labeled
secondary antibody (anti-goat IgG or anti-rabbit IgG) for 1
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Table 1: Composition of experimental diets.
% Content Normal diet High-fat diet
Casein-80-mesh 19.0 25.8
L-cystine 0.3 0.4
Corn starch 29.9 0.0
Maltodextrin 10 3.3 16.2
Sucrose 33.2 8.9
Cellulose, BW200 4.7 6.5
Soybean oil 2.4 3.2
Lard 1.9 31.7
Mineral mix S10026 0.9 1.3
Dicalcium phosphate 1.2 1.7
Calcium carbonate 0.5 0.7
Potassium citrate 1.6 2.1
Vitamin mix V10001 0.9 1.3
Choline bitartrate 0.2 0.3
hour at room temperature. After several washing steps, the
immunoreactive bands were detected by chemiluminescence
using West-one (iNtRON Biotechnology).
2.8. Image Analysis. All image analysis was performed with
ImageMaster 2D Elite software, version 3.1 (Amersham Phar-
macia Biotechnology). The signal intensity of each band was
analyzed by lowest background subtraction and normalized
by band intensity of Akt (for Akt-p) and actin (for perilipin).
2.9. In Vivo Antiobesity Activity. Male Sprague-Dawley
rats aged 6-week-old, weighing 170∼190 g (Samtaco, Seoul,
Korea), were housed four per cage in a laminar airflow room
maintained at a temperature of 22 ± 1∘C and a relative
humidity of 55 ± 1%. After the animals were given a standard
laboratory diet for oneweek, theywere randomly divided into
a normal diet group (ND) (𝑛 = 6), high-fat diet group (HFD)
(𝑛 = 6), and a high-fat diet + ABB group (HFD + ABB)
(𝑛 = 6). Table 1 shows theHFD composition. Rats in theHFD
groupwere orally administered saline once a day, while rats in
theHFD+ABB groupwere orally administered 0.5 g ABB/kg
body weight in saline. All experimental rats were allowed
free access to the diet and water during the experimental
period. The research was conducted in accordance with the
internationally accepted principles for laboratory animal use
and care as found in US guidelines (NIH publication #85-
23, revised in 1985). Food intake and body weights were
recorded daily for 6 weeks. The rats were euthanized by
anesthetic overdose andbloodwas taken for triglyceride, total
cholesterol, LDL cholesterol, and HDL cholesterol analysis
(ARC Laboratory, South Korea).
2.10. Statistical Analysis. Data are presented as mean ± SEM.
Analysis was performed by ANOVA, with Bonferroni’s test
for multiple comparisons, and by 𝑡-test, using SPSS 11.0
software. A 𝑃 value of <0.05 was considered statistically
significant.
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Figure 1: Effect of various herbal medicines on cellular lipid
droplets in cultured 3T3-L1 adipocytes. Differentiating 3T3-L1 cells
were treated every 2 days with 10𝜇g/mL of herbal medicines in
adipocyte-induction media and stained with oil red O on day 8.The
accumulation of lipid contents was detected at 490 nm after oil redO
dye was dissolved in isopropanol. Results represent themean ± SEM
of four independent experiments ( ∗𝑃 < 0.005 versus control). CTL
(control), Achyranthes bidentata Blume (ABB), Morus alba Linn
(MAL), Leonurus sibiricus Linn (LSL), Dioscorea batatas Decaisne
(DBD), Eucommia ulmoides Oliver (EUO), Scrophularia buerg-
eriana Miquel (SBM), Phellodendron amurense Ruprecht (PAR),
Nelumbo nucifera Gaertner (NNG), Schizonepeta tenuifolia Briquet
(STP), Siegesbeckia pubescensMakino (SPM).
3. Results
3.1. Effects of 10 Herbal Medicines on Lipid Accumulation.
The antiadipogenic effects of 10 herbal medicines were
determined by oil red O staining. Postconfluent 3T3-L1 pre-
adipocytes were treated with 10 𝜇g/mL of a herbal medicine
every 2 days, while the preadipocytes were differentiated
into adipocytes. Figure 1 shows that, in contrast to control
cells and other herb-treated cells, the cells treated with
Achyranthes bidentata Blume (ABB) demonstrated a sig-
nificant reduction of lipid accumulation. The oil red O
staining result of ABB-treated cells showed a 36% inhibitory
effect on lipid content in 3T3-L1 adipocytes. Therefore, ABB
was subjected to further analysis to investigate its possible
antiadipogenic effect on adipocyte differentiation.
3.2. Effect of Achyranthes bidentata Blume on Cell Viability.
To examine the cell viability of ABB on 3T3-L1 adipocyte
differentiation, postconfluent 3T3-L1 preadipocytes were
maintained in adipocyte-induction media and were exposed
to various concentrations of ABB (1, 5, 10, and 25 𝜇g/mL) and
they were treated every 2 days with 0–25 𝜇g/mL of ABB for
8 days in adipocyte-induction media. As shown in Figure 2,
none of the concentrations of ABB affected cell viability in
3T3-L1 adipocytes, showing that ABB has no cytotoxic effects
at concentrations up to 25𝜇g/mL in 3T3-L1 adipocytes.
3.3. Effect of Achyranthes bidentata Blume on Lipid Accumu-
lation. The effects of ABB on adipocyte differentiation and
cellular lipid drops are shown in Figure 3. On the 8th day
of treatment with various concentrations of ABB (1, 5, 10,
and 25 𝜇g/mL) in adipocyte-induction media, intracellular
lipid drops were examined by oil red O staining. Control
cells showed a large amount of lipid drop accumulation,
but the cell treated with 1 𝜇g/mL, 5𝜇g/mL, 10 𝜇g/mL, and
25 𝜇g/mL of ABB showed relatively smaller amounts of lipid
droplet accumulation as observed by reduced oil red staining
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Figure 2: Effect of ABB on cell viability in cultured 3T3-L1 adipocytes. Differentiating 3T3-L1 cells were treated every 2 days with 0–25𝜇g/mL
of ABB for 8 days in adipocyte-induction media. Cell viability was calculated as a percentage of MTT metabolisms in controls. Results
represent the mean ± SEM of four independent experiments.
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Figure 3: Effect of ABB on cellular lipid droplets and cell viability in cultured 3T3-L1 adipocytes. Differentiating 3T3-L1 cells were treated
every 2 days with 0–25 𝜇g/mL of ABB for 8 days in adipocyte-induction media. (a) Intracellular lipids were stained with oil red O (scale bar;
20 𝜇m). (b) The accumulation of lipid contents was detected at 490 nm after oil red O dye was dissolved in isopropanol. Results represent
mean ± SEM of four independent experiments ( ∗𝑃 < 0.05).
(Figure 3). The reduction of lipid accumulation is a result
of an inhibitory effect of ABB on adipocyte differentiation
in 3T3-L1. The cell viability result showed that ABB had no
cellular toxicity (Figure 2).
3.4. Effects of Achyranthes bidentata Blume on Expression of
Phospho-Akt and Perilipin. The results of oil red O and cell
viability showed that ABB inhibits intracellular lipid accu-
mulation without affecting cell viability in 3T3-L1 adipocytes.
Next the effect of ABB on the expression of adipogenic
and lipolysis factor in 3T3-L1 adipocytes was examined. To
examine the molecular mechanisms and whether inhibition
of lipid accumulation in adipocyte differentiation resulted
from ABB-mediated expression of adipogenic protein, the
effect of ABB on the level of phosphorylated Akt (phospho-
Akt) was first examined by Western blot from 3T3-L1 cell
lysates treated with ABB at various concentrations (1, 5,
10, and 25 𝜇g/mL). Serine/threonine kinase Akt is a down-
stream target of phosphatidylinositol-3-kinase (PI3-Kinases)
in adipocyte differentiation [3, 4]. As shown in Figure 4, treat-
ment with 25𝜇g/mL of ABB decreased the level of phospho-
Akt in comparison to control cells. Since intracellular lipid
accumulation in the differentiation of 3T3-L1 preadipocytes
into adipocytes can also decrease by the acceleration of
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Figure 4: Effects of ABB on Akt-p and perilipin A/B expression. Differentiating 3T3-L1 cells were treated every 2 days with 0–25𝜇g/mL of
ABB for 8 days in adipocyte-induction media. (a) Expression level of Akt-p and perilipin was normalized by Akt and actin and quantified as
relative intensities (b) and (c). Results represent mean ± SEM of three independent experiments ( ∗𝑃 < 0.05).
lipolysis along with decreased expression of the lipid droplet-
associated protein perilipin [5, 6], the next examination was
whetherABB alters perilipin expression in 3T3-L1 adipocytes.
As shown in Figure 4, Western-blot result from 3T3-L1 cell
lysates treated with various concentrations (1, 5, 10, and
25 𝜇g/mL) of ABB in 3T3-L1 adipocytes showed that ABB had
no significant effect on perilipin protein expression. Taken
together, these results suggest that ABB effects a reduction
of lipid accumulation through modulation of Akt signaling
pathway in 3T3 -L1 adipocytes, and ABB has no effect on the
alteration of lipolysis via perilipin expression.
3.5. Effect of Achyranthes bidentata Blume on Rats Fed with
High-Fat Diet. To investigate the antiadipogenic effect of
ABB in vivo, ABB (0.5 g/kg per day) was orally administrated
to HFD-induced rats for 6 weeks (Figure 6). Table 2 shows
that therewas no significant difference in food intake between
HFD and HFD + ABB groups. However, the final body
weight was significantly lower in the HFD + ABB group
when compared to those of the HFD group. Moreover,
the concentration of triglyceride in plasma was remark-
ably decreased by ABB administration compared to rats
fed only the HFD (Figure 5(b)). Although there was no
significant difference observed in total cholesterol, HDL, and
LDL (Figure 5(a)), oral administration of ABB suppressed
HFD-induced weight gains as well as triglyceride concentra-
tions in plasma without affecting food intake.
4. Discussion
Obesity has become a major health problem worldwide. It is
associated with heart diseases, hypertension, cancer, and type
2 diabetes [17]. Even though alternative therapies for obesity
such as herbal medicine treatments have long been used in
eastern cultures, few herbal medicines have been investigated
to prove their efficacy and mechanisms compared to western
drugs.
The present study demonstrated for the first time that
Achyranthes bidentata Blume (ABB) root water extract causes
a significant inhibition of lipid accumulation without cyto-
toxicity (Figure 2) and a decrease in the expression of Akt
phosphorylation in 3T3-L1 adipocytes (Figure 3), suggesting
that ABB extract may block adipogenesis by inhibition of the
Akt pathway, which is a major signal pathway for adipocyte
differentiation activated by insulin/IGF signaling. Since ABB
inhibited lipid accumulation during differentiation of 3T3-L1
preadipocytes into adipocytes, high-fat-diet (HFD)-induced
obese rats were orally administrated ABB water extract for
6 weeks to verify the antiobesity effect of ABB in vivo. The
animal study revealed that the bodyweight increase caused by
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Table 2: Weight gain and food intake in normal diet, high-fat diet, and high-fat diet + ABB groups for six weeks.
Ingredient (%) Normal diet High-fat diet High-fat diet + ABB
Body weight (g)
Initial 183.9 ± 2.0 184.5 ± 2.8 183.8 ± 1.8
Final 449.5 ± 13.3 549.2 ± 28.6 480.9 ± 15.1∗
Food intake (g) 183.0 ± 2.9 145.7 ± 1.8 146.9 ± 2.3
Data represents the mean ± SEM, ABB: Achyranthes bidentata Blume (0.5 g/kg body weight/daily). ∗𝑃 < 0.05, when compared to the high-fat diet group (𝑛 =
6 per group).
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Figure 5: Effect of ABB on lipid profiles. (a) Effect of ABB on total cholesterol, HDL-Chol, and LDL-Chol and (b) triglyceride level in normal
diet (ND), high fat diet (HFD), and HFD +ABB-fed rats groups after six weeks. Results represent mean ± SEM ( ∗𝑃 < 0.05 versus HFD, 𝑛 = 6
per group).
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Figure 6: Growth curve. Weight gain of rat in normal diet group
(ND) (𝑛 = 6), high-fat diet group (HFD) (𝑛 = 6), and a high-fat diet
+ ABB group (HFD + ABB) (𝑛 = 6).
a HFD was significantly decreased by ABB, but ABB did not
change food intake (Table 2). One possible explanationwould
be that ABB may impair adipogenesis and decrease lipid
accumulation in adipocytes. Although examinationswere not
made of phosphorylated-Akt expression in adipocytes from
ABB-administrated rats, it is supported by the in vitro study
that showed that ABB causes a decrease in lipid accumulation
by inhibition of Akt phosphorylation in 3T3-L1 adipocytes.
It is also possible that ABB may induce increased energy
expenditure in HFD-induced obese rats. However, this must
be confirmed by further investigation.
ABB is known to contain a variety of bioactive compo-
nents including steroids, alkaloids, saponins, flavonoids, and
phenols [18, 19]. It is well known that phenolic acids and
flavonoids have pharmacological activities such as antioxi-
dant, anti-inflammatory, and anticancer activities [20, 21].
Recently, Hsu and Yen [22] investigated the effect of phenolic
acids and flavonoids on the inhibition of adipogenesis in
3T3-L1 adipocytes. Interestingly, among 15 phenolic acids
and 6 flavonoids tested in that study, o-coumaric acid and
rutin showed the highest inhibition of GAPDH activity and
intracellular triglyceride accumulation in 3T3-L1 adipocytes.
However, further studies should be performed to identify
what component(s) in ABB and what changes in another
adipogenesis marker(s) is (are) responsible for its antiadipo-
genesis in this study.
The results obtained in the present study showed antiadi-
pogenic effects of ABB on preadipocytes into adipocyte
differentiation and molecular mechanisms in 3T3-L1 cells,
which was confirmed in the HFD-induced obese rat model.
ABB water extract inhibited lipid accumulation in differ-
entiating 3T3-L1 adipocyte by a decrease in the protein
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expression of phosphorylated Akt. Moreover, body weight
gain and plasma triglyceride levels were effectively decreased
in HFD-fed rats with ABB (g/kg) administrated for 6 weeks.
Taken together, these results suggest that ABB could have a
beneficial effect by inhibition in adipogenesis and reducing
body weight gain in rats fed a HFD.
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